TrialJournal of cardiovascular pharmacology2015

First-in-Man Study With Inclacumab, a Human Monoclonal Antibody Against P-selectin.

Christophe Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.